Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 15 Sep 2026
ArriVent BioPharma, Inc. (AVBP) Gets a Buy From GuggenheimTipRanks · 15 Sep 2026
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)TipRanks · 15 Sep 2026
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 15 Sep 2026
A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $45Market news · 15 Sep 2026
H.C. Wainwright Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Raises Target Price to $47Market news · 17 Aug 2026
Citi Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Cuts Target Price to $40Market news · 15 Aug 2026
Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)TipRanks · 14 Aug 2026
A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $50Market news · 14 Aug 2026
Analysts Offer Insights on Healthcare Companies: Kyverna Therapeutics, Inc. (KYTX) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 14 Aug 2026
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Alterity Therapeutics (ATHE)TipRanks · 13 Aug 2026
A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $42 to $50Market news · 13 Aug 2026
No comments yet — be the first to weigh in on AVBP.